| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/24/1998 | EP0849361A2 Novel ligands of the neuropeptide receptor HFGAN72 |
| 06/24/1998 | EP0849276A1 Anti-obesity proteins |
| 06/24/1998 | EP0848757A1 The use of the wap of mmtv regulatory sequences for targeted expression of linked heterologous genes in human mammary cells, including human mammary carcinoma cells |
| 06/24/1998 | EP0848756A1 Materials and methods relating to the attachment and display of substances on cell surfaces |
| 06/24/1998 | EP0848755A1 Vegf-related protein |
| 06/24/1998 | EP0848753A2 Nucleic acid molecule encoding tgf receptor having modified growth inhibition, and its use |
| 06/24/1998 | EP0848720A2 Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers |
| 06/24/1998 | EP0848719A2 Inhibitors of fibrin cross-linking and/or transglutaminases |
| 06/24/1998 | EP0848718A1 Cytolytic bradykinin antagonists |
| 06/24/1998 | EP0848614A1 Isolation of microdomains of caveolae and gpi-anchored proteins |
| 06/24/1998 | EP0848613A1 Analogs for specific oligosaccharide-neuregulin interactions and uses thereof |
| 06/24/1998 | EP0751785B1 Combinations of thrombolytically active proteins and anticoagulants, and uses thereof |
| 06/24/1998 | EP0679161B1 Thiazolidine derivatives, preparation thereof and drugs containing same |
| 06/24/1998 | EP0666842B1 Hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors |
| 06/24/1998 | EP0658117B1 Treatment of tumors with neurotrophic factors and cell proliferation inhibitors |
| 06/24/1998 | EP0642333B1 Method and composition for the treatment of disorders involving immunological dysfunction |
| 06/24/1998 | CN1185811A Antigen presentation system on retrovirus-like particles |
| 06/24/1998 | CN1185786A Sugar-modified cytostatics |
| 06/24/1998 | CN1185785A Peptide antagonists of cellular mitogenesis and motogenesis and their therapeutic use |
| 06/24/1998 | CN1185739A Cyclic peptide antifungal agents |
| 06/24/1998 | CN1185338A 胶原蛋白口服制剂及制备方法 Collagen oral formulation and preparation methods |
| 06/24/1998 | CN1185319A Tumor-blood-vessel growth inhibitor and medicinal composition |
| 06/24/1998 | CN1038841C Polypeptide and anti-hiv agent prepared therefrom |
| 06/23/1998 | US5770727 Crosslinked hemoglobin product comprising tetrameric and oligomeric hemoglobin units |
| 06/23/1998 | US5770720 Provides means for regulating transcription in cells and a means for suppressing transcription of a target gene in a host cell |
| 06/23/1998 | US5770717 Nucleic acid encoding a stress-responsive subunit of human RNA polymerase II |
| 06/23/1998 | US5770703 Nucleic acids encoding peptides of the envelope region of HIV-2 and peptides, polypeptides, and methods for producing the peptides and polypeptides of the HIV-2 envelope gene |
| 06/23/1998 | US5770700 Liquid factor IX formulations |
| 06/23/1998 | US5770699 Process for production of inhibited forms of activated blood factors |
| 06/23/1998 | US5770693 Calpain-inhibiting peptide analogs of the kininogen heavy chain |
| 06/23/1998 | US5770690 Bax omega protein and methods |
| 06/23/1998 | US5770689 Hepatitis E virus ORF Z peptides |
| 06/23/1998 | US5770688 Administering a therapeutically active amount of melittin or its derivative as viricide consisting of hymenoptra venom, an active protein or a polypeptide component of hymenoptra venom |
| 06/23/1998 | US5770687 Comformationally constrained backbone cyclized somatostatin analogs |
| 06/23/1998 | US5770620 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
| 06/23/1998 | US5770600 Methionine sulfone and S-substituted cysteine sulfone derivatives as enzyme inhibitors |
| 06/23/1998 | US5770581 Gene transcription and ionizing radiation: methods and compositions |
| 06/23/1998 | US5770580 Somatic gene therapy to cells associated with fluid spaces |
| 06/23/1998 | US5770577 BDNF and NT-3 polypeptides selectively linked to polyethylene glycol |
| 06/23/1998 | US5770576 Administering glutamic acid-tryptophan dipeptide to stimulate binding function of t-lymphocytes |
| 06/23/1998 | US5770574 Long-chain alkylamides of amino acids and peptides with anti-proliferative and anti-inflammatory properties |
| 06/23/1998 | US5770573 CS-1 peptidomimetics, compositions and methods of using the same |
| 06/23/1998 | US5770572 Methods and compositions using molecular decoyants for ameliorating the undesired effects of foreign agents which bind to endogenous receptors |
| 06/23/1998 | US5770571 Method and agents for inhibiting protein aging |
| 06/23/1998 | US5770570 Method of delivering a vasoactive intestinal polypeptide, an encapsulated vasoactive intestinal polypeptide, and a method of making the encapsulated vasoactive intestinal polypeptide |
| 06/23/1998 | US5770569 Diagnostic and therapeutic agents using a lymphocyte adhesion receptor for high endothelium CD44 |
| 06/23/1998 | US5770568 Variants of bovine pancreatic trypsin inhibitor produced by recombinant DNA technology, process expression vector and recombinant host therefor and pharmaceutical use thereof |
| 06/23/1998 | US5770567 Sensory and motor neuron derived factor (SMDF) |
| 06/23/1998 | US5770565 Peptides for reducing or inhibiting bone resorption |
| 06/23/1998 | US5770564 Platelet aggregation inhibitors |
| 06/23/1998 | US5770563 Antiproliferative agents, antitumor agents |
| 06/23/1998 | US5770562 Products and methods for improving keratinocyte adhesion to the dermis |
| 06/23/1998 | US5770561 Method for potentiating BPI protein product bactericidal activity by administration of LBP protein products |
| 06/23/1998 | US5770560 Method for increasing tissue oxygenation using fish hemoglobin exhibiting a root effect |
| 06/23/1998 | US5770559 Promoting the inhalation drug delivery by forming solid particles from a slurries comprising a complexes of active drug with amphiphilic material |
| 06/23/1998 | US5770455 Identifier tag which is a microchip that is pre-encoded or encodable with information that is related back to a detector when the tag is pulsed with electromagnetic radiation |
| 06/23/1998 | US5770445 Genetic engineering |
| 06/23/1998 | US5770444 Growth differentiation factor-6 |
| 06/23/1998 | US5770443 Apoptosis-modulating proteins, DNA encoding the proteins and methods of use thereof |
| 06/23/1998 | US5770432 Obesity associated genes |
| 06/23/1998 | US5770429 Transgenic non-human animals capable of producing heterologous antibodies |
| 06/23/1998 | US5770426 Tissue plasminogen activator having zymogenic or fibrin specific properties |
| 06/23/1998 | US5770425 Human tissue plasminogen activator variants |
| 06/23/1998 | US5770404 Fermentation, incubation to produce culture product synthetic hemoglobin |
| 06/23/1998 | US5770403 Genetically engineered nucleic acid coding for antibodies which bind to and block interleukins |
| 06/23/1998 | US5770402 DNA encoding macrophage inflammatory protein-1γ |
| 06/23/1998 | US5770401 Such as cutaneous, ocular, nasal and bronchial allergic disease; interleukins and tumor necrosis factor receptors; competitive binding |
| 06/23/1998 | US5770396 Isolation characterization, and use of the human beta subunit of the high affinity receptor for immunoglobulin E |
| 06/23/1998 | US5770387 Antibodies to mammalian NK antigens and uses |
| 06/23/1998 | US5770384 Method for determining compound interaction with E2 binding proteins |
| 06/23/1998 | US5770377 Detecting and preventing deactivation of tumor suppressors or anticarcinogenic agents |
| 06/23/1998 | US5770374 Methods for identifying oncogenes and anti-oncogenes |
| 06/23/1998 | US5770366 Melanoma-inhibiting protein |
| 06/23/1998 | US5770361 Protein conferring an inducible resistance to glycopeptides, particularly in gram-positive bacteria |
| 06/23/1998 | US5770233 Container filled with infusion liquids and infusion preparation |
| 06/23/1998 | US5770228 Platelet derived growth factor gel formulation |
| 06/23/1998 | US5770213 Endotoxin-free; otitis media, sinusitis, meningitis, and chronic pulmonary obstructive disease |
| 06/23/1998 | US5770210 Expression of htlv-iii envelope proteins by recombinant dna methods, aids vaccine |
| 06/23/1998 | US5770209 Acceleration of wound healing using connective tissue growth factor |
| 06/23/1998 | US5770202 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
| 06/23/1998 | US5770201 HA-2 antigenic peptide |
| 06/23/1998 | US5770199 Method for virus inactivation in the presence of polyalkylene glycol as well as the pharmaceutical preparation obtained therewith |
| 06/23/1998 | US5770198 Anticoagulants |
| 06/23/1998 | US5770197 Methods for regulating the immune response using B7 binding molecules and IL4-binding molecules |
| 06/23/1998 | US5770196 Modified antibody variable domains and therapeutic uses thereof |
| 06/23/1998 | US5770195 Antitumor |
| 06/23/1998 | US5770194 Fibrin sealant compositions and methods for utilizing same |
| 06/23/1998 | US5770191 Active C-terminal peptides of interferon--gamma and their use |
| 06/23/1998 | US5770190 Method of treatment of acute leukemia with inteleukin-10 |
| 06/23/1998 | US5769895 Delivery system for biologically active growth or morphogenetic factors and a method for preparing such a delivery system |
| 06/23/1998 | CA2166296C Stabilized pharmaceutical peptide compositions |
| 06/23/1998 | CA2038579C Utilization of enzymes |
| 06/20/1998 | CA2225273A1 Vitronectin receptor antagonists, their preparation and their use |
| 06/20/1998 | CA2217698A1 Anti-obesity proteins |
| 06/18/1998 | WO1998026086A1 Novel methods and compositions for treatment of autoimmune diseases |
| 06/18/1998 | WO1998026080A1 Method for expression of heterologous proteins in yeast |
| 06/18/1998 | WO1998026077A1 USE OF A VECTOR EXPRESSING DNA POLYMERASE β AS MEDICINE |
| 06/18/1998 | WO1998026076A1 Novel human carbonyl reductase |
| 06/18/1998 | WO1998026074A1 Fusion protein comprising the whole or part of the pp65 protein of human cmv, useable in particular for preparing a vaccine |
| 06/18/1998 | WO1998026070A1 Bone stimulating factor |